News and breakthroughs in tissue analysis, biomarkers, and pathology technology.
Flagship publishes article on using IHC and digital imaging to improve patient selection for PD-L1 therapy
First NSCLC study using cTA to report IHC data in immuno-oncology Westminster, CO, June 7, 2018 – Flagship is proud to co-author the research paper,
Flagship to Present Computational Tissue Analysis Solutions for Advancing Drug Development at AACR Annual Meeting
Download Flagship AACR reference Westminster, CO, April 12, 2018 – Flagship Biosciences’ cTA® and decision support platform will be featured in four scientific poster presentations
Westminster, CO, April 10, 2018 – The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Flagship Biosciences, based on results
Ready-to-use and custom image analysis meets current and future development needs Westminster, CO, February 12, 2018 – Flagship Biosciences is adding to its menu of
January 26, 2018 – Flagship is proud to partner with Summit Therapeutics in its efforts to advance therapies for patients with Duchenne Muscular Dystrophy (DMD).